City
Epaper

No strong evidence to show acupuncture, music therapy work for autism: Study

By IANS | Updated: August 28, 2025 17:55 IST

New Delhi, Aug 28 There is no strong evidence to support the use of complementary and alternative treatments ...

Open in App

New Delhi, Aug 28 There is no strong evidence to support the use of complementary and alternative treatments such as acupuncture and music therapy for autism, finds a study on Thursday.

Researchers from the Paris Nanterre University, Paris Cité University in France and the University of Southampton in the UK showed that the safety of these treatments was rarely assessed.

"Many parents of autistic children, as well as autistic adults, turn to complementary and alternative medicines hoping they may help without unwanted side effects," said Professor Richard Delorme, Head of the Child and Adolescent Psychiatry Unit at Robert Debré Hospital in Paris.

"However, it is necessary to carefully consider evidence from rigorous randomised trials before concluding that these treatments should be tried," Delorme added.

For the study, published in the journal Nature Human Behaviour, the team assessed 248 meta-analyses, including 200 clinical trials involving over 10,000 participants.

Researchers investigated the efficacy and safety of complementary, alternative, and integrative medicines (CAIMs) to treat autism.

They looked at 19 types of treatment, including animal-assisted interventions, acupuncture, herbal medicine, music therapy, probiotics, and Vitamin D.

The team also created an online platform to make it easier for people to see the evidence they generated on different CAIMS.

Autistic people can find it hard to communicate, understand how people think or feel, be overwhelmed by sensory information, become anxious in unfamiliar surroundings, and carry out repetitive behaviours.

All of this can interfere with their quality of life, and up to 90 per cent report having used CAIMs at least once in their lifetime.

While some treatments showed potential, most studies were supported by weak or poor-quality evidence, so the effects are not reliable. Concerningly, safety assessments were missing for most treatments, with less than half of CAIMs having had any evaluation of the acceptability, tolerability, or adverse events, the team said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

BusinessRBI may cut rates by 25 bps in December as inflation falls to multi-year low: Report

BusinessRevolutionizing Connectivity: Commbitz's eSIM Solution for Seamless Travel

BusinessSamsung Electronics' Q3 operating profit largest in 3 years on strong chip demand

TechnologyPMSGY accelerated residential rooftop solar, installed 4,946MW capacity till July: Report

Other Sports2nd Test: Rahul hits unbeaten 58 as India beat WI by seven-wicket to sweep series 2-0

Technology Realted Stories

TechnologySamsung Electronics logs largest operating earnings in over 3 yrs in Q3

TechnologyInflation likely around 0.45 pc next month, time for decisive RBI actions: SBI

TechnologyIndian stock markets open higher amid global trade concerns, Q2 earnings buzz

TechnologyStartups are driving forces behind nation’s digital transformation: C-DOT

TechnologySouth Korea’s ICT exports surge 14 pc in September on record semiconductor shipments